Published in J Natl Compr Canc Netw on July 01, 2007
Efficacy of Pazopanib in Gastrointestinal Stromal Tumors (GIST) (PAZOGIST) | NCT01323400
Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. Int J Clin Oncol (2008) 2.65
Gastrointestinal stromal tumors. Virchows Arch (2010) 2.28
Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor. Cancer Discov (2013) 2.11
Esophagogastric junction gastrointestinal stromal tumor: resection vs enucleation. World J Gastroenterol (2010) 1.92
Endoscopic resection of small gastrointestinal stromal tumors. Dig Dis Sci (2010) 1.69
Laparoscopic versus open gastric resections for primary gastrointestinal stromal tumors (GISTs): a size-matched comparison. Ann Surg Oncol (2011) 1.69
How many molecular subtypes? Implications of the unique tumor principle in personalized medicine. Expert Rev Mol Diagn (2012) 1.66
Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol (2009) 1.62
Gastrointestinal stromal tumor. J Gastrointest Oncol (2012) 1.57
A guide for the diagnosis and management of gastrointestinal stromal cell tumors. Nat Rev Gastroenterol Hepatol (2009) 1.41
Partial gastrectomy using natural orifice translumenal endoscopic surgery (NOTES) for gastric submucosal tumors: early experience in humans. Surg Endosc (2009) 1.32
Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. J Clin Invest (2007) 1.31
The role of IGF-1R in pediatric malignancies. Oncologist (2009) 1.27
Current management and prognostic features for gastrointestinal stromal tumor (GIST). Exp Hematol Oncol (2012) 1.23
Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea. J Korean Med Sci (2010) 1.21
Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum. Int J Colorectal Dis (2013) 1.19
Genetic aberrations of gastrointestinal stromal tumors. Cancer (2008) 1.18
Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol (2013) 1.15
Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial. BMC Cancer (2011) 1.14
Clinical practice guideline for accurate diagnosis and effective treatment of gastrointestinal stromal tumor in Korea. Cancer Res Treat (2012) 1.14
Malignant tumours of the small intestine: a review of histopathology, multidetector CT and MRI aspects. Br J Radiol (2011) 1.13
Advances in the surgical management of gastrointestinal stromal tumor. Adv Surg (2011) 1.10
Laparoscopic versus open gastric resection for larger than 5 cm primary gastric gastrointestinal stromal tumors (GIST): a size-matched comparison. Surg Endosc (2014) 1.10
Long term survival results for gastric GIST: is laparoscopic surgery for large gastric GIST feasible? World J Surg Oncol (2012) 1.10
Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors. Cancer (2010) 1.08
Long-term and surgical outcomes of laparoscopic surgery for gastric gastrointestinal stromal tumors. Surg Endosc (2014) 1.03
Management of resectable gastrointestinal stromal tumor. Hematol Oncol Clin North Am (2009) 1.03
Endoscopic treatment for gastrointestinal stromal tumor: Advantages and hurdles. World J Gastrointest Endosc (2015) 1.01
Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors. BMC Med Genet (2010) 1.01
Primary Extra-gastrointestinal Stromal Tumor of Retroperitoneum. Clin Med Insights Oncol (2012) 1.00
Gastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patients. World J Surg Oncol (2011) 0.99
Imatinib treatment for gastrointestinal stromal tumour (GIST). J Cell Mol Med (2009) 0.97
Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications. Clin Sarcoma Res (2012) 0.97
Gastrointestinal stromal tumors: thirty years experience of an institution. World J Gastroenterol (2011) 0.97
Evaluation of self-reported progression and correlation of imatinib dose to survival in patients with metastatic gastrointestinal stromal tumors: an open cohort study. J Gastrointest Cancer (2010) 0.96
Proapoptotic activity of bortezomib in gastrointestinal stromal tumor cells. Cancer Res (2009) 0.95
Esophageal gastrointestinal stromal tumor: report of 7 patients. Cancer Imaging (2012) 0.95
Endoscopic approach to subepithelial lesions. Therap Adv Gastroenterol (2014) 0.95
Recurrent rectal GIST resected successfully after preoperative chemotherapy with imatinib mesylate. Int J Clin Oncol (2008) 0.94
Update on the treatment of gastrointestinal stromal tumors (GISTs): role of imatinib. Biologics (2010) 0.93
Local resection by combined laparoendoscopic surgery for duodenal gastrointestinal stromal tumor. Diagn Ther Endosc (2011) 0.93
Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET. J Nucl Med (2010) 0.93
Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors. Cancer (2010) 0.92
Surgical resection should be taken into consideration for the treatment of small gastric gastrointestinal stromal tumors. World J Surg Oncol (2013) 0.91
Gastrointestinal stromal tumors and shock. J Emerg Trauma Shock (2009) 0.90
Long-term outcomes of percutaneous endoscopic intragastric surgery in the treatment of gastrointestinal stromal tumors at the esophagogastric junction. Surg Endosc (2015) 0.89
Gastrointestinal stromal tumors (GISTs): an updated experience. Dig Dis Sci (2010) 0.89
Submucosal tunneling techniques: current perspectives. Clin Exp Gastroenterol (2014) 0.88
A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del). Mod Pathol (2013) 0.88
Clinical implications of mutational analysis in gastrointestinal stromal tumours. Br J Cancer (2008) 0.87
Laparoscopic resection of large gastric GISTs: feasibility and long-term results. Surg Endosc (2014) 0.86
A systems biological approach to identify key transcription factors and their genomic neighborhoods in human sarcomas. Chin J Cancer (2011) 0.86
Laparoscopic management of gastric gastrointestinal stromal tumors. World J Gastrointest Endosc (2014) 0.86
Gastrointestinal stromal tumor: a bridge between bench and bedside. Gastric Cancer (2010) 0.85
Gastrointestinal stromal tumor of the stomach: How to manage? World J Gastrointest Endosc (2010) 0.85
Laparoscopic wedge resection of the stomach for gastrointestinal stromal tumor (GIST): non-touch lesion lifting method. Gastric Cancer (2013) 0.85
KIT and BRAF heterogeneous mutations in gastrointestinal stromal tumors after secondary imatinib resistance. Gastric Cancer (2014) 0.85
Gastrointestinal stromal tumor of the rectum with scapular metastasis: a case report. J Med Case Rep (2012) 0.84
Clinical practice guidelines for patients with gastrointestinal stromal tumor in Taiwan. World J Surg Oncol (2012) 0.84
Surgical management of gastrointestinal stromal tumors: a single center experience. Wideochir Inne Tech Maloinwazyjne (2014) 0.83
Concomitant jejunal sarcomatoid carcinoma and gastric GIST in patient with polymyalgia rheumatica: A case report. Int J Surg Case Rep (2013) 0.83
Gastrointestinal stromal tumors as an incidental finding in patients with a presumptive diagnosis of ovarian cancer. J Gynecol Oncol (2012) 0.83
Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the phase III GRID trial. Int J Clin Oncol (2015) 0.83
Laparoscopic management of gastrointestinal stromal tumours: review at a Canadian centre. Can J Surg (2012) 0.81
The diagnostic importance of matrix metalloproteinase-7 and nestin in gastrointestinal stromal tumors. Med Sci Monit (2014) 0.81
Optimal management of GIST tumors located near the gastroesophageal junction: Case report and review of the literature. Int J Surg Case Rep (2016) 0.81
Gastrointestinal stromal tumors-diagnosis and management: a brief review. Ochsner J (2008) 0.81
Current endoscopic ultrasound-guided approach to incidental subepithelial lesions: optimal or optional? Ann Gastroenterol (2015) 0.81
Comparison of Endoscopic and Open Resection for Small Gastric Gastrointestinal Stromal Tumor. Transl Oncol (2015) 0.81
Totally laparoscopic resection for a large gastrointestinal stromal tumor of stomach. J Gastric Cancer (2011) 0.81
Laparoscopic resection for gastrointestinal stromal tumors in the stomach. Surg Today (2011) 0.81
Rare anorectal neoplasms: gastrointestinal stromal tumor, carcinoid, and lymphoma. Clin Colon Rectal Surg (2009) 0.81
Surgical management of gastrointestinal stromal tumors of the stomach. JSLS (2014) 0.80
Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors. BMC Med (2010) 0.80
Performance and clinical role of endoscopic ultrasound fine needle aspiration for diagnosing gastrointestinal intramural lesions. Clin Endosc (2013) 0.79
Clinical outcomes of gastrointestinal stromal tumor in southern Thailand. World J Gastrointest Oncol (2012) 0.79
Neurotensin receptor 1 is expressed in gastrointestinal stromal tumors but not in interstitial cells of Cajal. PLoS One (2011) 0.79
Pathology of gastrointestinal stromal tumors. Clin Med Insights Pathol (2012) 0.79
Laparoscopic sleeve gastrectomy in the treatment of gastrointestinal stroma tumours in morbid obese patients. BMJ Case Rep (2009) 0.78
Long-term survival after enucleation of a giant esophageal gastrointestinal stromal tumor. World J Gastroenterol (2014) 0.78
Image-based Approach for Surgical Resection of Gastric Submucosal Tumors. J Gastric Cancer (2010) 0.78
Endoscopic-assisted laparoscopic resection for gastric subepithelial tumors. Surg Endosc (2015) 0.78
Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST. Int J Clin Oncol (2010) 0.78
Imatinib as the first and only treatment in Europe for adult patients at significant risk of relapse following gastrointestinal stromal tumor removal. Clin Exp Gastroenterol (2010) 0.77
Non-Exposed Endoscopic Wall-Inversion Surgery for Gastrointestinal Stromal Tumor of the Stomach: First Case Report in Korea. Clin Endosc (2016) 0.77
Gastrointestinal stromal tumors. Pediatr Surg Int (2009) 0.76
Gastrointestinal stromal tumour in pregnancy. BMJ Case Rep (2011) 0.76
Drug-drug interactions with imatinib: An observational study. Medicine (Baltimore) (2016) 0.76
Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs). Onco Targets Ther (2009) 0.76
SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis. World J Gastroenterol (2015) 0.76
Gastrointestinal stromal tumors: Recommendations on diagnosis, therapy and follow-up care in Austria. Wien Klin Wochenschr (2009) 0.76
Gastrointestinal Stromal Tumor: May Mimic Adnexal Mass. Glob J Health Sci (2015) 0.75
Clinico-pathological characteristics and prognostic factors of gastrointestinal stromal tumors among a Chinese population. Int J Clin Exp Pathol (2015) 0.75
[Rectal stromal tumor: report of a case]. Pan Afr Med J (2014) 0.75
Gastrointestinal stromal tumor: psychosocial characteristics and considerations. Support Care Cancer (2012) 0.75
Using Forceps Biopsy after Small Submucosal Dissection in the Diagnosis of Gastric Subepithelial Tumors. J Korean Med Sci (2016) 0.75
Colonoscopy Leads to A Diagnosis of A Jejunal Gastrointestinal Stromal Tumour (GIST). Gastroenterology Res (2011) 0.75
Prognostic role of microscopically positive margins for primary gastrointestinal stromal tumors: a systematic review and meta-analysis. Sci Rep (2016) 0.75
Oncologic Safety of Laparoscopic Wedge Resection with Gastrotomy for Gastric Gastrointestinal Stromal Tumor: Comparison with Conventional Laparoscopic Wedge Resection. J Gastric Cancer (2015) 0.75
Accomplishments in 2008 in the management of gastrointestinal stromal tumors. Gastrointest Cancer Res (2009) 0.75
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med (2010) 36.78
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med (2002) 24.88
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med (2015) 13.08
Delivering affordable cancer care in high-income countries. Lancet Oncol (2011) 12.79
High-throughput oncogene mutation profiling in human cancer. Nat Genet (2007) 12.68
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet (2004) 11.37
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol (2003) 11.33
PDGFRA activating mutations in gastrointestinal stromal tumors. Science (2003) 11.11
Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer. J Clin Oncol (2003) 9.72
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol (2008) 8.72
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet (2009) 8.69
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. N Engl J Med (2016) 8.53
Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg (2002) 8.30
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet (2012) 8.00
Multidisciplinary management of lung cancer. N Engl J Med (2004) 7.13
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol (2002) 6.85
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol (2007) 6.82
Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med (2008) 6.82
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet (2007) 6.76
Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis. Lancet Oncol (2011) 6.69
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol (2010) 6.47
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT. J Clin Oncol (2008) 6.43
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med (2010) 6.28
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol (2005) 6.20
Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol (2007) 6.11
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033. J Clin Oncol (2008) 6.11
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy. Nat Genet (2010) 6.10
Molecular correlates of imatinib resistance in gastrointestinal stromal tumors. J Clin Oncol (2006) 6.00
Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors. J Clin Oncol (2008) 5.98
Soft-tissue sarcomas in adults. N Engl J Med (2005) 5.97
Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation. Clin Cancer Res (2005) 5.44
Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors. J Clin Oncol (2008) 5.28
NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw (2010) 5.20
One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA (2012) 5.00
Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer (2006) 4.92
Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol (2012) 4.91
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature (2008) 4.87
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations. N Engl J Med (2015) 4.78
Altered bone and mineral metabolism in patients receiving imatinib mesylate. N Engl J Med (2006) 4.71
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc (2015) 4.70
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. J Clin Oncol (2010) 4.69
Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med (2006) 4.52